Revel Pharmaceuticals

San Francisco, CA · Founded 2019 · Privately Held (backing)

Developer of therapeutic enzymes designed for degrading molecular damage associated with aging. Revel Pharmaceuticals is based in San Francisco, CA and was founded in 2019. It was valued at $15 million at its early-stage round in Mar 2022, the last priced event on record. It has raised $14.7 million across 3 recorded rounds; the latest was a $5.8 million early-stage round in Feb 2022.

PMV mark · valuation
$15.0M
Oct 2026
Priced at
its early-stage round
Mar 2022
Total raised
$14.7M
Last round
Early Stage VC
Feb 2022
How much has Revel Pharmaceuticals raised?
$14.7Macross 3 recorded rounds · Dec 2019 – Feb 2022

Most recently, Revel Pharmaceuticals raised $5.8M in its Early Stage VC (Feb 2022).

Free account
More of Revel Pharmaceuticals with a free account
  • ·Watch Revel Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Revel Pharmaceuticals round by round

3 rounds
Feb 2022Early Stage VC$5.8MSEC filing▮
3 investors participated
Mar 2021Seed Round$800KSEC filing▮
2 investors participated
Dec 2019Seed Round$533KSEC filing▮
2 investors participated

How much has Revel Pharmaceuticals raised?

Revel Pharmaceuticals has raised $14.7 million in total; 3 of its rounds are on record, from 2019 on. The largest on record was an $800,000 seed round in Mar 2021; the most recent was a $5.8 million early-stage round in Feb 2022.

Revel Pharmaceuticals has filed 3 Form Ds with the SEC since 2020, most recently in Mar 2022 ($5.8 million sold to 3 investors).

Revel Pharmaceuticals investors

9 investors are on record for Revel Pharmaceuticals, including Gaingels, Formic Ventures, Starbloom Capital and Kizoo Technology Capital. The early-stage round in Feb 2022 drew 3 investors.

For fundraisers
Raising for a company like Revel Pharmaceuticals?

9 investors have backed Revel Pharmaceuticals.

See all 9 investors →

Frequently asked about Revel Pharmaceuticals

How much has Revel Pharmaceuticals raised?
Revel Pharmaceuticals has raised $14.7M in total across 3 recorded funding rounds.
When was Revel Pharmaceuticals's last funding round?
Revel Pharmaceuticals's most recent recorded round was Early Stage VC in Feb 2022, raising $5.8M.